Make it Ecstatically Loud!
Blessed by an auto-immune disease at the age of 11, being different wasn’t really an option at the time,...
Search Results
You searched for: Research Portfolio
Results found: 856
COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds
NEW YORK, NY, May 28, 2020. More than one third of people with lupus experienced significant issues filling their...
Expert Global Task Force Issues Recommendations for Physical Activity and Exercise in People with SLE
An international task force recently published their recommendations for physical activity and exercise in people with systemic lupus erythematosus...
Fatigue an Issue in Skin Lupus
July 18, 2019
A new study published in The British Journal of Dermatology provides evidence that fatigue is a key...
Lupus Research Alliance Mourns the Loss of Congresswoman Eddie Bernice Johnson
The national lupus community lost a passionate advocate with the passing of former Congresswoman Eddie Bernice Johnson (D-TX).
As many...
LRA Congratulates Election of Grantee Katherine Fitzgerald, PhD to the National Academy of Sciences
May 14, 2021
The Lupus Research Alliance (LRA) is proud to share that one of our grantees Katherine A. Fitzgerald,...
Interview with Eliza Ngan-Dittgen, LANtern® at HSS for Asian American Pacific Islander Heritage Month
May 25, 2022
In recognition of Asian American Pacific Islander Heritage Month, we spoke with the Program Supervisor of LANtern®...
How is Lupus Diagnosed?
While no single test can determine whether a person has lupus, several laboratory tests may help the doctor confirm...
Community Spotlight: How Chief Advancement Officer Nicole Capossela is Collaborating for a Cure
From her very first day, Nicole Capossela brought an unmistakable sense of purpose, passion, and possibility to the Lupus...
LRA is Unraveling Lupus Heterogeneity to Turn Complexity to Cure
July 22, 2021
Why is lupus so tough to treat? Why is it so difficult to test possible new treatments...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA
NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...